|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 12-09-2004
LONDON (Reuters) - Smoking not only damages health, it is bad for the brain too, according to a Scottish study spanning nearly 60 years.
LONDON (Reuters) - Teenagers and young men should keep their laptops off their laps because they could damage fertility, an expert said Thursday.
NEW YORK (Reuters Health) - Some men with abnormally small penises gave a portion of their left arm so that surgeons could create a more normal-sized organ. The operation, known as total phallic reconstruction, dramatically improved their quality of life and, for some, allowed them to experience a full sex life for the first time.
NEW YORK (Reuters Health) - African American women who report experiences of discrimination based on their race or skin color appear to have an increased risk of poor pregnancy outcomes, according to the findings of two new studies.
LONDON (Reuters) - Scientists said Wednesday they have identified key genes involved in the body's response to HIV, which causes AIDS -- a finding that could narrow the search for an effective vaccine against the deadly illness.
BANGKOK (Reuters) - Thai surgeons will perform the world's first live sex change operation on Friday in an attempt to boost the country's booming cosmetic surgery industry.
CHICAGO (Reuters) - Baxter International Inc. on Thursday said it halted a late-stage European trial of a flu vaccine because of higher-than-expected rates of fever and other symptoms.
AMSTERDAM (Reuters) - China cannot abandon the social responsibility of major public health crises such as SARS for the sake of economic development, Chinese premier Wen Jiabao said on Thursday.
BOSTON (Reuters) - The drug Exelon, prescribed to restore memory in Alzheimer's patients, may also offer some help for people who develop dementia from Parkinson's disease, researchers said on Wednesday.
NEW YORK (Reuters) - Introgen Therapeutics Inc., a gene therapy company, on Thursday said its experimental breast cancer treatment showed promise in a mid-stage clinical trial, driving its shares up 24 percent.
|
|
